ARCHIVES

Blistering Resignation Letters Declare CPRIT Outside Mainstream of Science

This article is from The Cancer Letter archive.

Vol. 38 No. 38 | October 12, 2012

Download PDF Visit The Full Archive

Related Articles

ACS Picks Up Study Of tobacco Industry Influence On Voting By State Legislators

May 3, 1996

NCI Plans SBIR “Bridge” Award To Commercialize Technology.

April 11, 2008

AACR Campaigns For Doubling Funding for Cancer Research In Three Years

April 25, 1997

Sledge Elected ASCO President

January 16, 2009

Oncology Nurses Urged To Help Set Agenda For Health Care Reform

May 29, 1992

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004